Li Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Li Zhang has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Bei Liu
Kunming General Hospital of Chengdu Military Region
1 shared publicationJun-Zhen Shi
Kunming General Hospital of Chengdu Military Region
1 shared publicationLi Li
1 shared publicationShu-Hua Chu
Department of Obstetrics and Gynecology, Kunming General Hospital of Chengdu Military Region, No. 212 Da-Guan Road, Kunming 650032, Yunnan Province, People's Republic of China
1 shared publicationYue-Wang Liu
Kunming General Hospital of Chengdu Military Region
1 shared publication
Latest Publications
- 8 November 2012
- Published by Springer Nature in Molecular Biology Reports
- Vol. 40 (1) , 1-6
Regulation of survival and chemoresistance by HSP90AA1 in ovarian cancer SKOV3 cells
Previous researches have showed that HSP90AA is important in ovarian cancer, but the mechanism of HSP90AA is still unknown. This study aimed to investigate the role of the potential therapy target protein HSP90AA1 in ovarian cancer. The level of HSP90AA1 in ovarian cancer SKOV3 cell line was altered by RNAi and overexpression. Survival of these cell lines was investigated by tetrazolium-based assay and fluorescence-activated cell sorter (FACS). The chemosensitivity to cisplatin of the cell was also tested by FACS when HSP90AA1 was overexpressed. HSP90AA1 RNAi inhibited the proliferation of ovarian cancer SKOV3 cell line and increased the apoptosis. Furthermore, overexpression of HSP90AA1 decreased the chemosensitivity to cisplatin of SKOV3 cells and overexpression of HSP90AA1 could partially rescue the survival rate of SKOV3 cells which were treated with cisplatin. HSP90AA1 is required for the survival and proliferation of SKOV3 cells. High level of HSP90AA1 can increase chemoresistance to cisplatin of SKOV3 cells.
- 8 November 2012
- Published by Springer Nature in Molecular Biology Reports
- Vol. 40 (1) , 1-6
Regulation of survival and chemoresistance by HSP90AA1 in ovarian cancer SKOV3 cells
Previous researches have showed that HSP90AA is important in ovarian cancer, but the mechanism of HSP90AA is still unknown. This study aimed to investigate the role of the potential therapy target protein HSP90AA1 in ovarian cancer. The level of HSP90AA1 in ovarian cancer SKOV3 cell line was altered by RNAi and overexpression. Survival of these cell lines was investigated by tetrazolium-based assay and fluorescence-activated cell sorter (FACS). The chemosensitivity to cisplatin of the cell was also tested by FACS when HSP90AA1 was overexpressed. HSP90AA1 RNAi inhibited the proliferation of ovarian cancer SKOV3 cell line and increased the apoptosis. Furthermore, overexpression of HSP90AA1 decreased the chemosensitivity to cisplatin of SKOV3 cells and overexpression of HSP90AA1 could partially rescue the survival rate of SKOV3 cells which were treated with cisplatin. HSP90AA1 is required for the survival and proliferation of SKOV3 cells. High level of HSP90AA1 can increase chemoresistance to cisplatin of SKOV3 cells.